Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production
礼来礼来(US:LLY) Investopedia·2025-12-11 05:45

Key Takeaways Eli Lilly said it plans to build a 6billionfacilityinAlabamatoproduceitsexperimentalweight−losspill,orforglipron.Thedrugmakeranticipatesseekingapprovalfororforglipronfromregulatorsbytheendoftheyear.Withdemandforweight−lossdrugssoaringandanagreementwiththeWhiteHousetoproducemoremedicineintheU.S.,EliLilly(LLY)istakingstepstoboostitsdomesticoutput.ThedrugmakersaidTuesdayitplanstobuilda6 billion facility in Alabama to produce its experimental weight-loss pill, orforglipron.The drugmaker anticipates seeking approval for orforglipron from regulators by the end of the year. With demand for weight-loss drugs soaring and an agreement with the White House to produce more medicine in the U.S., Eli Lilly (LLY) is taking steps to boost its domestic output. The drugmaker said Tuesday it plans to build a 6 billion facility in Huntsville, Alabam ...